Guillin Tang

78PUBLICATIONS

181CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyPredictive and prognostic markersBacteriologyRegenerative medicine (incl. stem cells)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (78)

Sort by Publication Date:

|Jul 06, 2026

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

|Jun 05, 2026

D-VRD induction and autologous transplant in patients ≥70 years.

|May 06, 2026

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

|May 04, 2026

Buffy Coat Enrichment Improves the Success Rate of Conventional Cytogenetics in Hypocellular Specimens: A Prospective Quality Improvement Study.

|Apr 14, 2026

Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.

Jayastu Senapati, Hagop M Kantarjian, Edward Ayoub

|Mar 12, 2026

Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Sanam Loghavi, Aziz Farhat, Trevor J Jamison

Pageof 13

Frequent Collaborators

24 joint publications

Sanam Loghavi

23 joint publications

Tapan M Kadia

22 joint publications

Naval G Daver

21 joint publications

Courtney DiNardo

20 joint publications

Farhad Ravandi-Kashani

19 joint publications

Hagop M Kantarjian

18 joint publications

Nicholas Short